MARKET

TTNP

TTNP

Titan Pharmaceut
NASDAQ
1.140
0.000
0.00%
After Hours: 1.100 -0.04 -3.51% 17:58 10/04 EDT
OPEN
1.160
PREV CLOSE
1.140
HIGH
1.170
LOW
1.130
VOLUME
16.92K
TURNOVER
0
52 WEEK HIGH
2.030
52 WEEK LOW
0.3496
MARKET CAP
16.68M
P/E (TTM)
-1.3143
1D
5D
1M
3M
1Y
5Y
BRIEF-Titan Pharmaceuticals Announces Board Expansion And Management Changes
BRIEF-Titan Pharmaceuticals Announces Board Expansion And Management Changes
Reuters · 08/16 17:50
Titan Pharmaceuticals Appoints David E. Lazar Interim Chairman, CEO; Expands Board After Election of Director Nominees
Titan Pharmaceuticals Appoints David E. Lazar Interim Chairman, CEO; Expands Board After Election of Director Nominees
MT Newswires · 08/16 11:23
BRIEF-Titan Pharma Received Confirmation From Nasdaq That Co Has Regained Compliance
BRIEF-Titan Pharma Received Confirmation From Nasdaq That Co Has Regained Compliance
Reuters · 07/22 20:40
Titan Pharmaceuticals Regains Nasdaq Compliance With Minimum Bid Price Requirement
MT Newswires · 07/22 16:22
BRIEF-Activist Investing Nominates Slate Of Director Candidates For Election To Board Of Titan Pharmaceuticals
BRIEF-Activist Investing Nominates Slate Of Director Candidates For Election To Board Of Titan Pharmaceuticals
Reuters · 07/11 12:09
Activist Investing Nominates Slate of Highly Qualified Director Candidates for Election to the Board of Directors of Titan Pharmaceuticals at Upcoming Special Meeting of Stockholders
NEW YORK, July 11, 2022 (GLOBE NEWSWIRE) -- David E. Lazar, Chief Executive Officer of Activist Investing LLC (together with its affiliates, “Activist Investing” or “we”), one of the largest stockholders of Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Tita...
GlobeNewswire · 07/11 12:00
Insider Buy: Titan Pharmaceuticals
MT Newswires · 07/11 07:18
Here's Why We're Watching Titan Pharmaceuticals' (NASDAQ:TTNP) Cash Burn Situation
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Simply Wall St. · 07/09 13:07
More
About TTNP
Titan Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in developing therapeutics using its long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. Its ProNeura continuous drug delivery system consists of a small, solid rod-shaped implant made from a mixture of ethylene-vinyl acetate (EVA), and a drug substance. Its product Probuphine (buprenorphine implant), is based on ProNeura technology, which is used for the maintenance treatment of opioid use disorder in clinically stable patients taking 8 milligrams (mg) or less a day of oral buprenorphine. Its product pipeline includes Kappa Opioid Receptor Agonist (TP-2021) Implant and Nalmefene Implant. Its TP-2021 is used for the treatment of moderate-to-severe chronic pruritus. Its Nalmefene Implant is used for the prevention of relapse in opioid use disorder (OUD) patients following detoxification from opioids.

Webull offers kinds of Titan Pharmaceuticals, Inc. stock information, including NASDAQ:TTNP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TTNP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TTNP stock methods without spending real money on the virtual paper trading platform.